Metraipolis › archive › dc_beb7181f3d76

Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes — Europe PMC PMID:41010765

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41010765
DOI
10.3390/jcm14186561
License (as archived)
solo-consultazione
Archived
2026-11-09T21:26:01.762Z
SHA-256 of the archived text
2ba404345013f482cafa58f5fe0ac33cdefe9bb283d44132437970968cfd445d
Stable URL of this page
https://metraipolis.com/documento/dc_beb7181f3d76

How to cite

Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes — Europe PMC PMID:41010765 — Europe PMC (en), https://europepmc.org/article/MED/41010765 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beb7181f3d76 (Metraipolis archive dc_beb7181f3d76, sha256 2ba404345013f482cafa58f5fe0ac33cdefe9bb283d44132437970968cfd445d)
BibTeX
@misc{dcbeb7181f3d76,
  title = {Thymoquinone Versus Metformin in Letrozole-Induced PCOS: Comparative Insights into Metabolic, Hormonal, and Ovarian Outcomes — Europe PMC PMID:41010765},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41010765},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beb7181f3d76; sha256 2ba404345013f482cafa58f5fe0ac33cdefe9bb283d44132437970968cfd445d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41010765. Agents can read the archived copy with the MCP tool read_document.